Felbamate and Oxycodone and Acetaminophen Capsules and Tablets
Determining the interaction of Felbamate and Oxycodone and Acetaminophen Capsules and Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Felbamate may reduce the blood levels of oxyCODONE in some cases, which may make the medication less effective in treating your condition. Additionally, if you have been receiving treatment with oxyCODONE, adding felbamate may cause you to experience unpleasant withdrawal symptoms such as watery eyes, runny nose, sneezing, yawning, excessive sweating, goose bumps, fever, chills, flushing, restlessness, irritability, anxiety, depression, pupil dilation, tremor, rapid heart beat, body aches, involuntary twitching and kicking, abdominal cramping, loss of appetite, nausea, vomiting, diarrhea, and weight loss. On the other hand, if you have been receiving both medications, discontinuing felbamate may increase the blood levels of oxyCODONE, which could lead to an overdose. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of opioids that are metabolized by the isoenzyme such as butorphanol, fentanyl, hydrocodone, methadone, and oxycodone. Reduced efficacy or withdrawal symptoms may occur in patients maintained on their narcotic pain regimen following the addition of a CYP450 3A4 inducer. Conversely, discontinuation of the inducer may increase opioid plasma concentrations and potentiate the risk of overdose and fatal respiratory depression.
MANAGEMENT: Pharmacologic response to the opioid should be monitored more closely whenever a CYP450 3A4 inducer is added to or withdrawn from therapy, and the opioid dosage adjusted as necessary.
- Liu S-J, Wang RI "Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome." Am J Psychiatry 141 (1984): 1287-8
- Tong TG, Pond SM, Kreek MJ, et al "Phenytoin-induced methadone withdrawal." Ann Intern Med 94 (1981): 349-51
- Bell J, Seres V, Bowron P, Lewis J, Batey R "The use of serum methadone levels in patients receiving methadone maintenance." Clin Pharmacol Ther 43 (1988): 623-9
- "Product Information. Ionsys (fentanyl)." Ortho McNeil Pharmaceutical, Raritan, NJ.
- "Product Information. Zohydro ER (HYDROcodone)." Zogenix, Inc, San Diego, CA.
- Raistrick D, Hay A, Wolff K "Methadone maintenance and tuberculosis treatment." BMJ 313 (1996): 925-6
- "Product Information. OxyContin (oxycodone)." Purdue Frederick Company, Norwalk, CT.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Pinzani V, Faucherre V, Peyriere H, Blayac JP "Methadone withdrawal symptoms with nevirapine and efavirenz." Ann Pharmacother 34 (2000): 405-7
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM "Rifampin-induced methadone withdrawal." N Engl J Med 294 (1976): 1104-6
- "Product Information. Butorphanol Tartrate (butorphanol)." Apotex Corporation, Weston, FL.
- Altice FL, Friedland GH, Cooney EL "Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone." AIDS 13 (1999): 957-62
- "Product Information. Diskets (methadone)." Cebert Pharmaceuticals Inc, Birmingham, AL.
- Holmes VF "Rifampin-induced methadone withdrawal in AIDS." J Clin Psychopharmacol 10 (1991): 443-4
- Bending MR, Skacel PO "Rifampicin and methadone withdrawal." Lancet 1 (1977): 1211
- "Product Information. Duragesic Transdermal System (fentanyl)." Janssen Pharmaceutica, Titusville, NJ.
- Finelli PF "Phenytoin and methadone tolerance." N Engl J Med 294 (1976): 227
- Otero MJ, Fuertes A, Sanchez R, Luna G "Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert." AIDS 13 (1999): 1004-5
Generic Name: acetaminophen / oxycodone
Brand name: Endocet 10/325, Endocet 25/325, Endocet 5/325, Endocet 75/325, Nalocet, Percocet 10/325, Percocet 25/325, Percocet 5/325, Percocet 75/325, Primalev, Primlev, Roxicet, Xartemis XR, Tylox, Roxilox, Endocet, Percocet 10/650, Percocet 75/500, Perloxx, Magnacet, Narvox, Xolox, Percocet
Synonyms: Acetaminophen and oxycodone, Oxycodone and Acetaminophen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Felbamate-Oxycodone and Acetaminophen Extended-Release Tablets
- Felbamate-Oxycodone and Acetaminophen Oral Solution
- Felbamate-Oxycodone and Acetaminophen Tablets
- Felbamate-Oxycodone and Aspirin
- Felbamate-Oxycodone and Ibuprofen
- Felbamate-Oxycodone and naloxone
- Oxycodone and Acetaminophen Capsules and Tablets-Felbamate Oral Suspension
- Oxycodone and Acetaminophen Capsules and Tablets-Felbamate Tablets
- Oxycodone and Acetaminophen Capsules and Tablets-Felbatol
- Oxycodone and Acetaminophen Capsules and Tablets-Felbatol (Felbamate Oral Suspension)
- Oxycodone and Acetaminophen Capsules and Tablets-Felbatol (Felbamate Tablets)
- Oxycodone and Acetaminophen Capsules and Tablets-Feldene